z-logo
Premium
Developing antisense oligonucleotide and short‐interfering RNA therapeutics – a few considerations
Author(s) -
Cotreau Monette M.
Publication year - 2015
Publication title -
clinical pharmacology in drug development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.711
H-Index - 22
eISSN - 2160-7648
pISSN - 2160-763X
DOI - 10.1002/cpdd.223
Subject(s) - small interfering rna , rna , rnase h , rnase p , messenger rna , gene silencing , oligonucleotide , rna silencing , rna interference , microbiology and biotechnology , dna , translation (biology) , biology , medicine , biochemistry , gene

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom